Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translation

Glioblastoma multiforme (GBM) is the most common and aggressive form of tumor of the central nervous system. Despite significant efforts to improve treatments, patient survival rarely exceeds 18 months largely due to the highly chemoresistant nature of these tumors. Importantly, misregulation of the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Liwak, Urszula, Jordan, Lindsay E., Von-Holt, Sally Davidson, Singh, Poonam, Hanson, Jennifer E.L., Lorimer, Ian A., Roncaroli, Federico, Holcik, Martin
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2013
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824522/
https://ncbi.nlm.nih.gov/pubmed/23965755
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares